{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:25:09Z","timestamp":1788996309017,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jiph.2022.01.011","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:53:06Z","timestamp":1642600386000},"page":"289-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery"],"prefix":"10.1016","volume":"15","author":[{"given":"Sali","family":"Abubaker Bagabir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla Khamis","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Abubaker Bagabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghdah","family":"Hashem Ateeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2022.01.011_bib1","article-title":"The essential facts of Wuhan novel coronavirus outbreak in China and epitope-based vaccine designing against 2019-nCoV","author":"Sarkar","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jiph.2022.01.011_bib2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.jiph.2020.07.019","article-title":"Epidemiologic surveillance for controlling Covid-19 pandemic: types, challenges and implications","volume":"13","author":"Ibrahim","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2022.01.011_bib3","article-title":"Omicron (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance","author":"Chen","year":"2021","journal-title":"ArXiv Prepr"},{"key":"10.1016\/j.jiph.2022.01.011_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/2150132720963634","article-title":"Exploring the potential of artificial intelligence and machine learning to combat COVID-19 and existing opportunities for LMIC: a scoping review","volume":"11","author":"Naseem","year":"2020","journal-title":"J Prim Care Community Health"},{"issue":"8","key":"10.1016\/j.jiph.2022.01.011_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10081048","article-title":"Artificial intelligence in surveillance, diagnosis, drug discovery and vaccine development against COVID-19","volume":"10","author":"Arora","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.jiph.2022.01.011_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104027","article-title":"COVID19 inhibitors: a prospective therapeutics","volume":"101","author":"Jawaid Akhtar","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jiph.2022.01.011_bib7","article-title":"Summoning a new artificial intelligence patent model: in the age of pandemic","volume":"1\u201349","author":"Yanisky-Ravid","year":"2020","journal-title":"Ssrn"},{"issue":"1","key":"10.1016\/j.jiph.2022.01.011_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-80363-5","article-title":"Classification and specific primer design for accurate detection of sars-cov-2 using deep learning","volume":"11","author":"Lopez-Rincon","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2022.01.011_bib9","article-title":"Potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches","volume":"307","author":"Zhavoronkov","year":"2020","journal-title":"Insilico Med Hong Kong Ltd A"},{"key":"10.1016\/j.jiph.2022.01.011_bib10","article-title":"AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2","author":"Tang","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jiph.2022.01.011_bib11","article-title":"Machine intelligence design of 2019-nCoV drugs","author":"Gao","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jiph.2022.01.011_bib12","article-title":"Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks","author":"Hofmarcher","year":"2020","journal-title":"Tech Rep"},{"key":"10.1016\/j.jiph.2022.01.011_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12539-020-00376-6","article-title":"Deep learning based drug screening for novel coronavirus 2019-nCov","volume":"12","author":"Zhang","year":"2020","journal-title":"Interdiscip Sci: Comput Life Sci"},{"key":"10.1016\/j.jiph.2022.01.011_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.csbj.2020.03.025","article-title":"Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model","volume":"18","author":"Beck","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.jiph.2022.01.011_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41392-021-00568-6","article-title":"A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19","volume":"6","author":"Ge","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jiph.2022.01.011_bib16","article-title":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+ CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","author":"Zhou","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jiph.2022.01.011_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiph.2022.01.011_bib18","doi-asserted-by":"crossref","unstructured":"Li B, Feng F, Yang G, Liu A, Yang N, Jiang Q, et al. Immunoglobulin G\/M and cytokines detections in continuous sera from patients with novel coronaviruses (2019-nCoV) infection. Available at SSRN: \u3008https:\/\/ssrn.com\/abstract=3543609\u3009. \u3008http:\/\/dx.doi.org\/10.2139\/ssrn.3543609\u3009.","DOI":"10.2139\/ssrn.3543609"},{"key":"10.1016\/j.jiph.2022.01.011_bib19","article-title":"Prediction of potential commercially inhibitors against SARS-CoV-2 by multi-task deep model","volume":"200300728","author":"Hu","year":"2020","journal-title":"arXiv Prepr arXiv"},{"key":"10.1016\/j.jiph.2022.01.011_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov"},{"issue":"11","key":"10.1016\/j.jiph.2022.01.011_bib21","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1021\/acs.jproteome.0c00316","article-title":"Repurpose open data to discover therapeutics for COVID-19 using deep learning","volume":"19","author":"Zeng","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jiph.2022.01.011_bib22","article-title":"Network medicine framework for identifying drug repurposing opportunities for COVID-19","author":"Gysi","year":"2020","journal-title":"ArXiv"},{"key":"10.1016\/j.jiph.2022.01.011_bib23","doi-asserted-by":"crossref","unstructured":"Wang Z, Li L, Yan J, Yao Y . Evaluating the traditional Chinese medicine (TCM) officially recommended in China for COVID-19 using ontology-based side-effect prediction framework (OSPF) and deep learning; 2020.","DOI":"10.20944\/preprints202002.0230.v1"},{"key":"10.1016\/j.jiph.2022.01.011_bib24","doi-asserted-by":"crossref","first-page":"170433","DOI":"10.1109\/ACCESS.2020.3024238","article-title":"DeepH-DTA: deep learning for predicting drug-target interactions: a case study of COVID-19 drug repurposing","volume":"8","author":"Abdel-Basset","year":"2020","journal-title":"IEEE Access"},{"key":"10.1016\/j.jiph.2022.01.011_bib25","article-title":"Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection","volume":"8","author":"Demirci","year":"2020","journal-title":"PeerJ"},{"issue":"3","key":"10.1016\/j.jiph.2022.01.011_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00296-021-04792-9","article-title":"SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis","volume":"41","author":"Velikova","year":"2021","journal-title":"Rheuma Int"},{"key":"10.1016\/j.jiph.2022.01.011_bib27","first-page":"11","article-title":"Design of multi epitope-based peptide vaccine against E protein of human 2019-nCoV: an immunoinformatics approach","author":"Abdelmageed","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jiph.2022.01.011_bib28","article-title":"Potential T-cell and B-cell epitopes of 2019-nCoV","author":"Fast","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jiph.2022.01.011_bib29","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2020.01581","article-title":"COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning","volume":"11","author":"Ong","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiph.2022.01.011_bib30","article-title":"Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach","author":"Rahman","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jiph.2022.01.011_bib31","first-page":"1","article-title":"In silico approach to design a multi-epitopic vaccine candidate targeting the non-mutational immunogenic regions in envelope protein and surface glycoprotein of SARS-CoV-2","author":"Susithra Priyadarshni","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jiph.2022.01.011_bib32","article-title":"A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets","author":"Russo","year":"2021","journal-title":"Brief Bioinform"},{"issue":"12","key":"10.1016\/j.jiph.2022.01.011_bib33","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/S2589-7500(20)30192-8","article-title":"Artificial intelligence in COVID-19 drug repurposing","volume":"2","author":"Zhou","year":"2020","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.jiph.2022.01.011_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare9080961","article-title":"Artificial intelligence for hospital health care: application cases and answers to challenges in European hospitals","volume":"9","author":"Klumpp","year":"2021","journal-title":"Healthcare"},{"issue":"1","key":"10.1016\/j.jiph.2022.01.011_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s41182-021-00360-w","article-title":"Emergence of highly infectious SARS-CoV-2 variants in Bangladesh: the need for systematic genetic surveillance as a public health strategy","volume":"49","author":"Hasan","year":"2021","journal-title":"Trop Med Health"},{"issue":"1","key":"10.1016\/j.jiph.2022.01.011_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jiph.2022.01.011_bib37","first-page":"1","article-title":"Artificial intelligence vs COVID-19: limitations, constraints and pitfalls","author":"Naud\u00e9","year":"2020","journal-title":"AI Soc"},{"issue":"10","key":"10.1016\/j.jiph.2022.01.011_bib38","doi-asserted-by":"crossref","DOI":"10.2196\/21476","article-title":"Artificial Intelligence for COVID-19: rapid review","volume":"22","author":"Chen","year":"2020","journal-title":"J Med Internet Res"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:10:55Z","timestamp":1761750655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034122000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1876034122000144"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2022.01.011","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2022.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}